Polyrizon (NASDAQ:PLRZ) Posts Earnings Results

Polyrizon (NASDAQ:PLRZ) issued its quarterly earnings data on Monday. The company reported ($0.40) EPS for the quarter, FiscalAI reports.

Polyrizon Stock Performance

PLRZ stock traded down $0.41 during trading on Monday, hitting $10.36. 4,472 shares of the stock traded hands, compared to its average volume of 64,384. The firm’s 50 day moving average is $11.62 and its two-hundred day moving average is $12.83. Polyrizon has a 1 year low of $2.88 and a 1 year high of $18.20.

Analysts Set New Price Targets

Several brokerages have recently commented on PLRZ. Weiss Ratings raised shares of Polyrizon from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, September 18th. Wall Street Zen downgraded Polyrizon from a “hold” rating to a “sell” rating in a research note on Saturday, September 12th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Polyrizon presently has an average rating of “Sell”.

About Polyrizon

Polyrizon Ltd. is an Israel-based biotechnology company developing hydrogel-based nasal products intended to provide localized protection in the nasal cavity. Its technology is designed to create a physical barrier that may help reduce exposure to airborne pathogens, allergens and other harmful particles before they enter the respiratory system.

The company’s platform focuses on nasal formulations and delivery systems that can adhere to the nasal mucosa and support applications in respiratory health.